drug development

Pharma

FDA drafts plan to cut down on biosimilar testing requirements

The FDA's newest draft guidance reinforces its stated commitment to streamlining biosimilar drug development by removing certain testing requirements.

Zoey Becker Mar 9, 2026 5:25pm

Fierce Biotech

BMS and Evinova pen global development partnership

Feb 9, 2026 2:33pm

cost cutting restructuring savings reduce spend

InflaRx charts layoffs, cost cuts to lift lead asset's prospects

Jan 8, 2026 11:03am

InflaRx may find path forward for COVID drug in skin disorder

Jan 2, 2026 10:25am

Argenx cans Vyvgart trials in thyroid eye disease over futility

Dec 15, 2025 10:00am

two jiggsaw puzzles connected with drawn hands shaking on the two puzzles

CDMOs Bora, Corealis unite for end-to-end oral solid dose work

Dec 9, 2025 4:44pm